Emilia D’Elia | Heart Failure | Best Researcher Award

Best Researcher Award

Emilia D’Elia
ASST Papa Giovanni XXIII, Italy

Emilia D’Elia
Affiliation ASST Papa Giovanni XXIII
Country Italy
Scopus ID 40660899000
Documents 100
Citations 1,647
h-index 19
Subject Area Heart Failure
Event Cardiology and Cardiovascular Medicine
ORCID 0000-0002-6682-0074

Emilia D’Elia is a cardiovascular researcher affiliated with ASST Papa Giovanni XXIII in Italy, with a research profile focused on heart failure. The supplied bibliometric record reports 100 documents, 1,647 citations, and an h-index of 19, providing measurable indicators of scholarly productivity and visibility within cardiovascular medicine.[1]

Abstract

Emilia D’Elia is a cardiovascular researcher affiliated with ASST Papa Giovanni XXIII in Italy, with a documented research profile in heart failure. Available bibliometric information identifies 100 documents, 1,647 citations, and an h-index of 19, indicating sustained publication activity and measurable academic visibility. Her subject specialization places her work within contemporary cardiovascular medicine, where heart failure research addresses diagnosis, treatment, outcomes, and disease management. The profile provides a quantitative basis for considering research recognition while acknowledging that bibliometric indicators should be interpreted alongside publication quality, originality, clinical relevance, collaboration, and broader contributions to cardiovascular science and patient care.[1]

Keywords

Emilia D’Elia; heart failure; cardiology; cardiovascular medicine; clinical research; scholarly impact; bibliometrics; citations; h-index; cardiovascular outcomes; ASST Papa Giovanni XXIII; Italy; research recognition; Best Researcher Award.

Introduction

Heart failure is a major area of cardiovascular research requiring evidence across prevention, diagnosis, pharmacological management, device therapy, and long-term outcomes. Contemporary clinical guidance emphasizes multidisciplinary and evidence-based approaches to improving outcomes for affected patients.[2] Researchers specializing in heart failure contribute to the development and evaluation of clinically relevant evidence.

Research Profile

The supplied profile identifies Emilia D’Elia with ASST Papa Giovanni XXIII in Italy and associates her principal subject area with heart failure. Her Scopus author identifier is 40660899000, while the reported record comprises 100 documents, 1,647 citations, and an h-index of 19. These indicators describe a research profile with established bibliometric visibility.[1]

Research Contributions

The available information supports characterization of D’Elia’s research within heart failure and cardiovascular medicine. Research in this field can contribute to understanding disease mechanisms, improving risk assessment, evaluating therapeutic strategies, and strengthening evidence-based clinical care. The documented publication and citation record provides measurable evidence of sustained engagement with the scientific literature.[1]

Publications

The supplied Scopus information reports 100 documents associated with the researcher profile. Because individual publication titles, journals, publication years, and article-level identifiers were not provided, this article does not assign specific publications or DOIs without verification. The complete bibliographic record can be reviewed through the linked Scopus author profile.[1]

Research Impact

The reported 1,647 citations and h-index of 19 provide quantitative measures of scholarly influence within the indexed research record. Citation metrics can assist in evaluating research visibility, although they do not independently establish methodological quality, originality, clinical effectiveness, or societal benefit. A balanced assessment should therefore consider both bibliometric and qualitative evidence.[1]

Award Suitability

Based on the supplied information, Emilia D’Elia presents characteristics relevant to consideration for a Best Researcher Award in cardiology and cardiovascular medicine, particularly through her documented activity in heart failure research and established bibliometric record. Final award assessment should additionally consider originality, publication quality, research leadership, clinical relevance, collaboration, and independently verifiable achievements.

Conclusion

Emilia D’Elia’s supplied academic profile reflects sustained research activity in heart failure and cardiovascular medicine, supported by 100 reported documents, 1,647 citations, and an h-index of 19. These indicators provide a quantitative foundation for academic recognition, while a complete award evaluation should incorporate verified publication quality, scientific originality, clinical significance, and broader research contributions.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Emilia D’Elia, Author ID 40660899000. Scopus.
    https://www.scopus.com/pages/authors/40660899000
  2. Journal article (2025.). SGLT2 inhibitors and new frontiers in heart failure treatment regardless of ejection fraction and setting.
    https://doi.org/10.1093/eurheartjsupp/suae117
  3. Journal article. (2026.). Sex-related disparities in elderly patients with heart failure with mildly reduced or preserved ejection fraction.
    https://doi.org/10.1093/eschf/xvaf022
  4. Cardiology and Cardiovascular Medicine. (2026.). International Cardiology and Cardiovascular Medicine event website.
    https://cardiology-conferences.pencis.com/

Ibtasam Wajid | Cardiovascular Diseases | Best Researcher Award

Mr. Ibtasam Wajid | Cardiovascular Diseases | Best Researcher Award

Shenzhen University | China

Mr. Ibtasam Wajid is an emerging researcher whose work focuses on the intersection of biomedical engineering, health informatics, and data science, with a particular interest in developing innovative machine learning and deep learning models for improving healthcare outcomes. His research explores how advanced computational techniques can be applied to disease prediction, medical imaging, and clinical decision support, contributing to the growing field of digital health transformation. With an academic background spanning biochemistry, health informatics, and biomedical research, he brings an interdisciplinary perspective to addressing complex challenges in modern medicine. He has authored three research documents, accumulating a total of six citations and holding an h-index of one, reflecting a steadily growing research impact at an early stage of his academic career. Alongside his research contributions, he has actively participated in mentoring undergraduate students, organizing technical workshops, and promoting collaborative learning environments within the scientific community. His ongoing studies and projects continue to focus on integrating artificial intelligence into healthcare systems to enhance accuracy, efficiency, and patient-centered care. Through his dedication to continuous learning and innovation, he demonstrates the potential to make lasting contributions to biomedical science and the advancement of data-driven healthcare solutions worldwide.

Profiles: Scopus | Google Scholar

Featured Publications

Sultan, H., Javed, I., Zubair, M., Iqbal, K., Bilal, M., Iqbal, J., & Wajid, I. (2021). Protein and polysaccharide-based biomaterial for the formation of composite bone scaffold. AlQalam Journal of Medical and Applied Sciences, 4(2), 80–88.

Wajid, I., Dan, L., & Wang, Q. (2025). Hybrid ensemble approaches for cardiovascular disease prediction: Leveraging interpretable AI for clinical insight. Intelligence-Based Medicine, 100297.

Ishaq, S., Afzal, S., Usmani, S. A., Wajid, I., Aziz, A., Tahir, R., Ahmad, A., & Ullah, A. (2025). Inflammatory cell death and leukemia treatment. Critical Reviews in Oncology/Hematology, 104909.

Boyoung Park | Epidemiology | Best Researcher Award

Prof. Boyoung Park | Epidemiology | Best Researcher Award

Prof. Boyoung Park, Hanyang University College of Medicine, South Korea

Professor Boyoung Park is a distinguished expert in preventive medicine, currently serving at Hanyang University College of Medicine in Seoul, South Korea. She leads the Bio-Big Data Center at the Hanyang Institute of Bioscience and Biotechnology. Her research, focusing on breast cancer risk factors and epidemiology, has been published in reputable journals such as the British Journal of Cancer and BMJ Open. In 2023, she was honored with the Kwangdong Cancer Academic Award by the Korean Cancer Association. Additionally, she contributes to the academic community as a senior editor for the Journal of Preventive Medicine & Public Health.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

🎓 EARLY ACADEMIC PURSUITS:

Professor Boyoung Park embarked on her medical education at the Catholic University of Daegu, where she earned her M.D. in 2006. Her passion for preventive medicine led her to Seoul National University College of Medicine, where she obtained her M.S. in 2010 and subsequently completed her Ph.D. in 2012. This strong academic foundation set the stage for her future contributions to epidemiology and cancer research.

💼 PROFESSIONAL ENDEAVORS:

Prof. Park’s career trajectory has been marked by prestigious positions in both academia and research institutions:

  • Director of the Bio-BigData Center at the Hanyang Institute of Bioscience and Biotechnology (2024–present)
  • Professor at the Department of Preventive Medicine, Hanyang University College of Medicine (2023–present)
  • Associate Professor at Hanyang University College of Medicine (2018–2023)
  • Assistant Professor at the National Cancer Center Graduate School of Cancer Science and Policy (2015–2018)
  • Associate Scientist at the National Cancer Control Institute, National Cancer Center (2012–2018)
  • Fellowship at the National Cancer Control Institute, National Cancer Center (2011–2012)
  • Residency in Preventive Medicine at Seoul National University College of Medicine (2008–2011)
  • Internship at Asan Medical Center, Seoul (2006–2007)

Her experience spans clinical practice, research, and academic leadership, demonstrating her commitment to advancing public health and epidemiology.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON EPIDEMIOLOGY:

Prof. Park has played a crucial role in cancer epidemiology, HIV research, and the development of disease risk assessment models. Her research interests include:

  • Cancer prevention and control
  • HIV/AIDS and chronic infectious diseases
  • Big data and epidemiological studies
  • Genome analysis and risk assessment models

🏆 RESEARCH GRANTS:

She has led multiple nationally funded projects, including:

  • Korea HIV/AIDS Cohort Study (2023–2024) – Principal Investigator
  • Korea Atomic Bomb Survivors Cohort and Genome Analysis (2020–2024) – Principal Investigator
  • Development of a Breast Cancer Risk Assessment Model (2021–2025) – Principal Investigator
  • Transfusion and Prognosis in Hepatobiliary & Pancreatic Surgery (2022–2025) – Principal Investigator

🏅 IMPACT AND INFLUENCE:

Prof. Park’s work has been widely recognized through prestigious awards and honors, such as:

  • National AIDS and STI Contributor Award (2023) – Korea Disease Control and Prevention Agency
  • Kwangdong Cancer Academic Award (2023) – Korean Cancer Association
  • Outstanding Paper Review Committee Award (2022) – Korean Society of Epidemiology
  • Excellent Researcher Award (2021) – Hanyang University
  • Young Epidemiologist Award (2015) – Korean Society of Epidemiology

📖 ACADEMIC CITATIONS AND EDITORIAL CONTRIBUTIONS:

Prof. Park serves as a Senior Editor and Editorial Board Member for leading medical journals:

  • Journal of Preventive Medicine & Public Health (Senior Editor)
  • Cancer Research and Treatment (Editorial Board Member)
  • Journal of Cancer Prevention (Editorial Board Member)

Her contributions to medical literature have significantly shaped the fields of epidemiology and public health.

🔮 LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Boyoung Park has established herself as a leading figure in preventive medicine and cancer epidemiology. Moving forward, she aims to:
 Advance big data-driven epidemiological research
Enhance public health policies for cancer prevention
Develop personalized risk assessment models for chronic diseases
Strengthen national and global health collaborations

Her groundbreaking work continues to shape the future of epidemiology, public health, and medical research in South Korea and beyond.

🌍CONCLUSION:

Professor Boyoung Park has made significant contributions to preventive medicine, epidemiology, and cancer research. As the Director of the Bio-Big Data Center at Hanyang University, her work in breast cancer risk assessment and public health continues to shape medical advancements. Recognized with prestigious awards, including the Kwangdong Cancer Academic Award, she remains a leading figure in medical research. Through her editorial roles and government advisory positions, she influences healthcare policies and scientific discourse. Her legacy will inspire future researchers and improve global public health outcomes.

TOP NOTABLE PUBLICATIONS

Economic Evaluation of Mass Screening as a Strategy for Hepatitis C Virus Elimination in South Korea

Authors: Hwa-young Choi, Kyung-ah Kim, Boyoung Park, Bo-youl Choi, Moran Ki

Journal: Journal of Infection and Public Health

Year: 2025

Korean Patients with Hereditary Cancer: A Prospective Multicentre Cohort Study Protocol Exploring Psychosocial and Health Outcomes

Authors: Jun-kyu Kim, Mi-Ae Jang, Jong-eun Park, Boyoung Park, Sun-young Kong

Journal: BMJ Open

Year: 2025

Associations Between Breastfeeding and Breast Cancer Risk Through Mammographic Breast Density in a Cohort of Korean Women

Authors: Soyeoun Kim, Thi Xuan Mai Tran, Mi-kyung Kim, Woojoo Lee, Boyoung Park

Journal: International Journal of Epidemiology

Year: 2025

Concordant and Discordant Breast Density Patterns by Different Approaches for Assessing Breast Density and Breast Cancer Risk

Authors: Yoosun Cho, Eunkyung Park, Yoosoo Chang, Shinho Kook, Seungho Ryu

Journal: Breast Cancer Research and Treatment

Year: 2025

A National Estimate of Mental Disorders and Mortality Outcomes in Cancer Survivors

Authors: Thi Xuan Mai Tran, Minsung Chung, Boyoung Park

Journal: Cancer

Year: 2025

Refining Breast Cancer Genetic Risk and Biology Through Multi-Ancestry Fine-Mapping Analyses of 192 Risk Regions

Authors: Guochong Jia, Zhishan Chen, Jie Ping, Jirong Long, Wei Zheng

Journal: Nature Genetics

Year: 2025

Carrier Frequency and Incidence of MUTYH-Associated Polyposis Based on Database Analysis in East Asians and Koreans

Authors: Jong-eun Park, Taeheon Lee, Eun-hye Cho, Chang-Seok Ki, Sun-young Kong

Journal: Annals of Laboratory Medicine

Year: 2025

Correction to: Height and Breast Cancer Risk in Premenopausal Korean Women Aged Under 40 Years of Age

Authors: Thi Xuan Mai Tran, Yoosoo Chang, Hye-rin Choi, Seungho Ryu, Boyoung Park

Journal: British Journal of Cancer

Year: 2024

Height and Breast Cancer Risk in Premenopausal Korean Women Aged Under 40 Years of Age: Epidemiology

Authors: Thi Xuan Mai Tran, Yoosoo Chang, Hye-rin Choi, Seungho Ryu, Boyoung Park

Journal: British Journal of Cancer

Year: 2024

Epidemiological Characteristics of HIV-Infected Individuals by the Registration for Special Exempted Calculation: A Nationwide Cohort Study

Authors: Yunsu Choi, Kyoung-hwan Ahn, Soomin Kim, Yoonhee Jun, Boyoung Park

Journal: Infection and Chemotherapy

Year: 2024